A neurotrophic preparation of low-molecular-weight peptides and amino acids derived from porcine brain tissue, used in several countries for neurological conditions but not FDA-approved.
Mechanism under study
Cerebrolysin is proposed to mimic the actions of endogenous neurotrophic factors, supporting neuronal survival and plasticity; because it is a mixture, its activity is attributed to multiple components rather than a single molecule.
Research-reported dosing
Used in several countries (not FDA-approved) for stroke, dementia, and TBI, typically as daily IV/IM courses of roughly 5-30 mL of the commercial solution. Supplied ready-to-use.
Not reconstituted — supplied as a ready-to-use sterile solution; diluted for infusion rather than mixed from a powder.
Open this mix in the calculator →Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
Cerebrolysin FAQ
What is Cerebrolysin?
A neurotrophic preparation of low-molecular-weight peptides and amino acids derived from porcine brain tissue, used in several countries for neurological conditions but not FDA-approved.
What is the half-life of Cerebrolysin?
Not a single molecule — it is a mixture of low-molecular-weight peptides and amino acids, so no single half-life applies.
What is the research-reported dosing for Cerebrolysin?
Used in several countries (not FDA-approved) for stroke, dementia, and TBI, typically as daily IV/IM courses of roughly 5-30 mL of the commercial solution. Supplied ready-to-use.
How is Cerebrolysin reconstituted?
Not reconstituted — supplied as a ready-to-use sterile solution; diluted for infusion rather than mixed from a powder.
Is Cerebrolysin FDA-approved?
Cerebrolysin has an approved status in at least one context — see the overview above for the specific brand, region, and indication. Research-grade material sold separately is for laboratory use only.
References
Related peptides
Semax
Synthetic ACTH(4-10) fragment analog
A synthetic peptide derived from a fragment of ACTH, developed in Russia and studied for nootropic and neuroprotective effects, typically administered intranasally in research.
Selank
Synthetic heptapeptide (tuftsin analog)
A synthetic analog of the immunomodulatory peptide tuftsin, developed in Russia and studied for anxiolytic (anti-anxiety) and cognitive effects, often administered intranasally in research.
DSIP
Nonapeptide
Delta Sleep-Inducing Peptide, a nonapeptide first isolated in connection with sleep regulation. Its effects in humans remain poorly characterized and inconsistent.